Ikena Oncology Inc reports results for the quarter ended in March - Earnings Summary

ImageneBio

13/05/2021 17:28

* Ikena Oncology Inc  IKNA.OQ  reported a quarterly adjusted
loss of $2.52​​ per share for the quarter ended in March. The
mean expectation of four analysts for the quarter was for a loss
of 68 cents per share.
* Revenue was $3.47 million​;  analysts expected $4.39 million. 
* Ikena Oncology Inc's reported EPS for the quarter was a loss
of $2.52​.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Ikena Oncology Inc shares had fallen by 30.8% this quarter.
* The company reported a quarterly loss of $9.72 million.
* Wall Street's median 12-month price target for Ikena Oncology
Inc is $28.50 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated May 13 at 04:28 p.m. GMT.
​All figures in US dollars